Abstract
Problem statement: Thyroid dysfunction in pregnant women can influence the outcome for mother and fetus at all stages of pregnancy. As the fetus is entirely dependent on maternal thyroid hormones for its development until about 13 weeks of gestation, it is important to ensure adequate thyroxine substitution in pregnant women during the first trimester. The aim of this prospective study was to explore whether hypothyroidic pregnant women are adequately levothyroxine (L-T4) substituted in early pregnancy. Approach: During March 2008 to July 2009, 93 pregnant females with thyroid diseases were followed at the outpatient department of INMAS. At the first visit 86 patients were on L-T4 substitution for hypothyroidism. Seven other patients had hyperthyroidism. The patients were regularly followed every 4-8 weeks during pregnancy for dose adjustment. Before each visit serum Free Thyroxine (FT4) and TSH concentrations were determined. Results: Of the 86 patients on thyroxine substitution for hypothyroidism 56 (65.12%) had serum TSH values within the reference range at their first TSH test. Thirty (34.9%) had TSH values outside the reference range. In 5 patients TSH was <0.27 μIU mL-1. Fifty (58.13%) of the patients had to increase their thyroxine dose during pregnancy. The initial L-T4 increase at the first evaluation during pregnancy was 17.46±30.8 μg day-1. In the 50 patients who needed to increase L-T4, 26% reached a definitive therapeutic dosage within 12th week of pregnancy, 24% within the 20th week and 50% within the 31st week. Conclusion/Recommendations: In 34.9% of pregnant women on L-T4 substitution for hypothyroidism, serum TSH values were abnormal when first tested and they had increased chances of fetal loss if not treated timely. Thyroid function in pregnant women on thyroxine substitution should be monitored as soon as pregnancy has been confirmed and carefully followed during pregnancy.
Highlights
Primary hypothyroidism is a common disorder in women of childbearing age, with an estimated prevalence of 2-3% of women during pregnancy (Abalovich et al, 2007)
The issue of suboptimal maternal thyroid function is especially crucial during the first 12-14 weeks of gestation; when the fetal brain development is entirely reliant on placental transfer of maternal thyroid hormone (Casey et al, 2005)
Current literature indicates that 50-85% of women with hypothyroidism who are being treated with L-T4 Statistical analysis: Statistical analysis was performed require an increase in their dose of this hormone after using one way ANOVA, followed by Bonferroni’s and they become pregnant
Summary
Primary hypothyroidism is a common disorder in women of childbearing age, with an estimated prevalence of 2-3% of women during pregnancy (Abalovich et al, 2007). Epidemiologic studies indicate that 0.4% of pregnant women have serum thyrotropin concentrations above 10 μU per milliliter at 15-18 weeks of gestation from either under-replacement of L-T4 therapy or undiscovered primary hypothyroidism (Allan et al, 2000). The analytical sensitivity and total precision values deficiencies in maternal thyroid hormone levels have for FT4 and TSH assays were 0.3 pM/L and 2.7% and been shown to adversely affect cognition, intellect 0.005 μIU/mL and 2.2%, respectively. Current literature indicates that 50-85% of women with hypothyroidism who are being treated with L-T4 Statistical analysis: Statistical analysis was performed require an increase in their dose of this hormone after using one way ANOVA, followed by Bonferroni’s and they become pregnant 43% of women with hypothyroidism who are taking L-T4 before pregnancy have elevated serum Thyroid Stimulating Hormone (TSH) concentrations. It is known that the pregnant women is the sole source of fetal supply of thyroid hormones from
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
